INR 5459.2
(-0.25%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.94 Billion INR | -27.86% |
2022 | 11.01 Billion INR | 23.21% |
2021 | 8.93 Billion INR | -9.37% |
2020 | 9.86 Billion INR | -16.17% |
2019 | 11.76 Billion INR | -33.14% |
2018 | 17.59 Billion INR | 77.5% |
2017 | 9.91 Billion INR | 12.74% |
2016 | 8.79 Billion INR | 12.95% |
2015 | 7.78 Billion INR | 9.91% |
2014 | 7.08 Billion INR | 9.25% |
2013 | 6.48 Billion INR | 9.09% |
2012 | 5.94 Billion INR | 18.94% |
2011 | 4.99 Billion INR | 16.2% |
2010 | 4.29 Billion INR | -24.32% |
2009 | 5.68 Billion INR | 1.36% |
2008 | 5.6 Billion INR | 14.5% |
2007 | 4.89 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q4 | 7.94 Billion INR | 0.0% |
2023 FY | 7.94 Billion INR | -27.86% |
2023 Q2 | 10.77 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 11.01 Billion INR | 23.21% |
2022 Q4 | 11.01 Billion INR | 0.0% |
2022 Q2 | 10.79 Billion INR | 0.0% |
2021 Q2 | 8.48 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 8.93 Billion INR | 0.0% |
2021 FY | 8.93 Billion INR | -9.37% |
2020 Q2 | 8.51 Billion INR | 0.0% |
2020 Q4 | 9.86 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 9.86 Billion INR | -16.17% |
2019 FY | 11.76 Billion INR | -33.14% |
2018 FY | 17.59 Billion INR | 77.5% |
2018 Q2 | 17.59 Billion INR | 0.0% |
2018 Q4 | 9.73 Billion INR | 0.0% |
2017 Q2 | 9.91 Billion INR | 0.0% |
2017 FY | 9.91 Billion INR | 12.74% |
2017 Q4 | 10.27 Billion INR | 0.0% |
2016 FY | 8.79 Billion INR | 12.95% |
2016 Q4 | 9.03 Billion INR | 0.0% |
2016 Q2 | 8.79 Billion INR | 0.0% |
2015 FY | 7.78 Billion INR | 9.91% |
2015 Q2 | 7.78 Billion INR | 0.0% |
2015 Q4 | 8.11 Billion INR | 0.0% |
2014 Q4 | 7.62 Billion INR | 0.0% |
2014 Q2 | 7.08 Billion INR | 0.0% |
2014 FY | 7.08 Billion INR | 9.25% |
2013 Q4 | 6.85 Billion INR | 0.0% |
2013 Q2 | 6.48 Billion INR | 0.0% |
2013 FY | 6.48 Billion INR | 9.09% |
2012 FY | 5.94 Billion INR | 18.94% |
2012 Q2 | 5.94 Billion INR | 0.0% |
2012 Q4 | 6.41 Billion INR | 0.0% |
2011 FY | 4.99 Billion INR | 16.2% |
2011 Q4 | 10.85 Billion INR | 0.0% |
2011 Q2 | 4.99 Billion INR | 0.0% |
2010 FY | 4.29 Billion INR | -24.32% |
2009 FY | 5.68 Billion INR | 1.36% |
2008 FY | 5.6 Billion INR | 14.5% |
2007 FY | 4.89 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Ajanta Pharma Limited | 46.38 Billion INR | 82.874% |
Amrutanjan Health Care Limited | 3.66 Billion INR | -116.523% |
Sigachi Industries Limited | 6.94 Billion INR | -14.435% |
Bal Pharma Limited | 3.2 Billion INR | -147.936% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 31.821% |
Medico Remedies Limited | 961.95 Million INR | -725.778% |
Lasa Supergenerics Limited | 1.5 Billion INR | -426.524% |
Venus Remedies Limited | 6.26 Billion INR | -26.727% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -54.233% |
Alpa Laboratories Limited | 1.82 Billion INR | -334.976% |
Nectar Lifesciences Limited | 21.91 Billion INR | 63.745% |
Shilpa Medicare Limited | 30.93 Billion INR | 74.319% |
Aarti Drugs Limited | 24.32 Billion INR | 67.342% |
Lupin Limited | 239.97 Billion INR | 96.69% |
Aurobindo Pharma Limited | 450.71 Billion INR | 98.238% |
Zydus Lifesciences Limited | 292.8 Billion INR | 97.287% |
Windlas Biotech Limited | 6.26 Billion INR | -26.853% |
Suven Life Sciences Limited | 2.84 Billion INR | -178.818% |
Eris Lifesciences Limited | 70.48 Billion INR | 88.731% |
Valiant Laboratories Limited | 3.42 Billion INR | -131.803% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 80.112% |
Solara Active Pharma Sciences Limited | 23.5 Billion INR | 66.211% |
Ipca Laboratories Limited | 111.01 Billion INR | 92.844% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 34.56% |
Achyut Healthcare Limited | 309.52 Million INR | -2466.409% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.071% |
Bajaj HealthCare Limited | 7.65 Billion INR | -3.821% |
RPG Life Sciences Limited | 5.12 Billion INR | -54.885% |
Mankind Pharma Limited | 119.63 Billion INR | 93.36% |
Laurus Labs Limited | 83.87 Billion INR | 90.529% |
Piramal Pharma Limited | 153.11 Billion INR | 94.812% |
Syncom Formulations (India) Limited | 4.04 Billion INR | -96.301% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 94.726% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 87.676% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 94.468% |
Unichem Laboratories Limited | 31.69 Billion INR | 74.936% |
Sequent Scientific Limited | 15.4 Billion INR | 48.431% |
Novartis India Limited | 9.24 Billion INR | 14.117% |
Wanbury Limited | 3.43 Billion INR | -131.259% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 64.759% |
Wockhardt Limited | 76.49 Billion INR | 89.615% |
Themis Medicare Limited | 5.66 Billion INR | -40.243% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -265.933% |
Jubilant Pharmova Limited | 115.48 Billion INR | 93.122% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 72.132% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 97.95% |
Divi's Laboratories Limited | 154.7 Billion INR | 94.865% |
NATCO Pharma Limited | 69.06 Billion INR | 88.498% |
Gufic Biosciences Limited | 10.92 Billion INR | 27.292% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 64.607% |
Ind-Swift Limited | 6.54 Billion INR | -21.374% |
FDC Limited | 24.68 Billion INR | 67.815% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -345.832% |
Granules India Limited | 55.2 Billion INR | 85.612% |
Medicamen Biotech Limited | 2.94 Billion INR | -169.711% |
Alkem Laboratories Limited | 155.74 Billion INR | 94.9% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 26.314% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -1587.159% |
Brooks Laboratories Limited | 904.45 Million INR | -778.276% |
Megasoft Limited | 3.65 Billion INR | -117.098% |
ZIM Laboratories Limited | 4.46 Billion INR | -77.78% |
Strides Pharma Science Limited | 58.39 Billion INR | 86.397% |
Neuland Laboratories Limited | 18.32 Billion INR | 56.653% |
Morepen Laboratories Limited | 12.93 Billion INR | 38.574% |
Hikal Limited | 24.87 Billion INR | 68.061% |
Indoco Remedies Limited | 21.44 Billion INR | 62.962% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 69.236% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -230.898% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -138.243% |
Hester Biosciences Limited | 6.62 Billion INR | -19.931% |